ATE306929T1 - Inositolphosphoglycan und ribose zur behandlung von ischämischen-reperfusionschaden - Google Patents

Inositolphosphoglycan und ribose zur behandlung von ischämischen-reperfusionschaden

Info

Publication number: ATE306929T1
Authority: AT; Austria
Prior art keywords: treatment; ribose; reperfusion injury; ischemic; inositol phosphoglycan
Prior art date: 1998-06-29

Application number

AT99922293T

Other languages

English (en)

Inventor

Thomas William Rademacher

Leslie Greenbaum

Patricia Mclean

Original Assignee

Sylus Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-29

Filing date

1999-05-12

Publication date

2005-11-15

1999-05-12 Application filed by Sylus Pharmaceuticals Ltd filed Critical Sylus Pharmaceuticals Ltd

2005-11-15 Application granted granted Critical

2005-11-15 Publication of ATE306929T1 publication Critical patent/ATE306929T1/de

Links

206010063837 Reperfusion injury Diseases 0.000 title abstract 2
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 title abstract 2
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 title abstract 2
SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 title 1
HMFHBZSHGGEWLO-AIHAYLRMSA-N alpha-D-ribose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-AIHAYLRMSA-N 0.000 title 1
CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 title 1
229960000367 inositol Drugs 0.000 title 1
CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 title 1
239000000203 mixture Substances 0.000 abstract 2
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 abstract 1
230000002438 mitochondrial effect Effects 0.000 abstract 1
210000000056 organ Anatomy 0.000 abstract 1
230000001590 oxidative effect Effects 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
238000002054 transplantation Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

AT99922293T 1998-06-29 1999-05-12 Inositolphosphoglycan und ribose zur behandlung von ischämischen-reperfusionschaden ATE306929T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9814039.5A GB9814039D0 (en)	1998-06-29	1998-06-29	Materials and methods relating to the prevention or treatment of ischaemia-reperfusion injury
PCT/GB1999/001499 WO2000000205A1 (en)	1998-06-29	1999-05-12	Inositolphosphoglycan and ribose for treatment of ischaemia-reperfusion injury

Publications (1)

Publication Number	Publication Date
ATE306929T1 true ATE306929T1 (de)	2005-11-15

Family

ID=10834599

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99922293T ATE306929T1 (de)	1998-06-29	1999-05-12	Inositolphosphoglycan und ribose zur behandlung von ischämischen-reperfusionschaden

Country Status (9)

Country	Link
US (1)	US6900182B1 (de)
EP (1)	EP1091743B1 (de)
JP (1)	JP2002519328A (de)
AT (1)	ATE306929T1 (de)
AU (1)	AU748892B2 (de)
CA (1)	CA2332969A1 (de)
DE (1)	DE69927815T2 (de)
GB (1)	GB9814039D0 (de)
WO (1)	WO2000000205A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001245463A1 (en) *	2000-03-07	2001-09-17	Millennium Pharmaceuticals, Inc.	26583, a novel serine/threonine phosphatase and uses therefor
US6953781B2 (en) *	2000-05-12	2005-10-11	Rodaris Pharmaceuticals Limited	Compounds and their uses
WO2007129618A1 (ja) *	2006-05-08	2007-11-15	National University Corporation Kagawa University	好中球の活性化および遊走因子の抑制剤およびその利用
CN106138071A (zh) *	2008-04-02	2016-11-23	生物能公司	核糖在对于急性心肌梗塞的第一反应中的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2930589B2 (ja) *	1986-10-06	1999-08-03	ザユニバーシィティオブバージニアアルミニパテンツファンデーション	外科手術中における改善された心臓保護のためのアデノシン，ヒポキサンチン及びリボース含有溶液の使用
US4871718A (en) *	1987-12-29	1989-10-03	Raymond A. Roncari	Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US6294520B1 (en) *	1989-03-27	2001-09-25	Albert T. Naito	Material for passage through the blood-brain barrier
AU725247B2 (en) *	1996-06-14	2000-10-12	Biostore New Zealand Limited	Compositions and methods for the preservation of living tissues
GB9618934D0 (en) *	1996-09-11	1996-10-23	Univ London	Inositol phosphoglycans for therapeutic use in the treatment of diabetes and obesity
DE19649350A1 (de) *	1996-11-28	1998-06-04	Hoechst Ag	Inositolglykane mit insulinartiger Wirkung

1998
- 1998-06-29 GB GBGB9814039.5A patent/GB9814039D0/en not_active Ceased
1999
- 1999-05-12 WO PCT/GB1999/001499 patent/WO2000000205A1/en not_active Ceased
- 1999-05-12 DE DE69927815T patent/DE69927815T2/de not_active Expired - Fee Related
- 1999-05-12 AT AT99922293T patent/ATE306929T1/de not_active IP Right Cessation
- 1999-05-12 EP EP99922293A patent/EP1091743B1/de not_active Expired - Lifetime
- 1999-05-12 JP JP2000556790A patent/JP2002519328A/ja active Pending
- 1999-05-12 US US09/719,909 patent/US6900182B1/en not_active Expired - Fee Related
- 1999-05-12 CA CA002332969A patent/CA2332969A1/en not_active Abandoned
- 1999-05-12 AU AU39402/99A patent/AU748892B2/en not_active Ceased

Also Published As

Publication number	Publication date
US6900182B1 (en)	2005-05-31
EP1091743A1 (de)	2001-04-18
GB9814039D0 (en)	1998-08-26
AU3940299A (en)	2000-01-17
EP1091743B1 (de)	2005-10-19
WO2000000205A1 (en)	2000-01-06
JP2002519328A (ja)	2002-07-02
CA2332969A1 (en)	2000-01-06
AU748892B2 (en)	2002-06-13
DE69927815T2 (de)	2006-07-20
DE69927815D1 (de)	2006-03-02

Similar Documents

Publication	Publication Date	Title
ID29393A (id)	2001-08-30	Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
MY121548A (en)	2006-02-28	Compounds and methods for the treatment of cancer
DE69733132D1 (de)	2005-06-02	Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
ATE173155T1 (de)	1998-11-15	Mittel zur künstlichen bräunung mit verbesserter stabilität
ATE334985T1 (de)	2006-08-15	Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
DE69327544D1 (de)	2000-02-10	Mischungen zum schutz und regenierung von geweben
ATE279181T1 (de)	2004-10-15	Verwendung von 5ht-6 antagonisten zur behandlung adhd
PT735890E (pt)	2002-09-30	Misturas de 2',3'-didesoxi-inosina e hidroxicarbamida para inibicao da disseminacao retroviral
MX9306960A (es)	1995-01-31	Composiciones de extracto de corteza de roble, compositiones sinteticasrelacionadas, y metodo para su utilizacion.
DK0751789T3 (da)	2003-09-08	Gel til behandling af hudsygdomme og til desinfektion af huden
BR9507730A (pt)	1997-09-23	Uso de formulações em gel como composições de tratamento
DK1112067T3 (da)	2006-09-04	Anvendelse af acetylcholinesteraseinhibitorer til fremstilling af farmaceutiske præparater til behandling af funktionelle og/eller organiske smertesyndromer
DE69731652D1 (de)	2004-12-23	Verfahren zur behandlung von endothelialen verletzungen
DK1039912T3 (da)	2002-10-28	Angiostatiske midler og præparater til behandling af GLC1A-glaukom
DK0920309T3 (da)	2002-12-09	Konjugeret linolensyre til bevaring eller forøgelse af mineralindhold i knogler
TR199701669A1 (xx)	2001-10-22	Deri preparasyonu i�in bile�imler.
ATE311853T1 (de)	2005-12-15	Verwendung von krillenzymen zur behandlung von zahnbelag
ATE222119T1 (de)	2002-08-15	Verwendung von erythropoietin zur behandlung von multiple myelom
IL144199A0 (en)	2002-05-23	Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
ATE306929T1 (de)	2005-11-15	Inositolphosphoglycan und ribose zur behandlung von ischämischen-reperfusionschaden
DE69927286D1 (de)	2005-10-20	Verwendung von humanen prostatazellinien zur behandlung von prostatakrebs
DE69922364D1 (de)	2005-01-05	Verfahren zur immunisierung und behandlung von h. pylori infektion
ATE251462T1 (de)	2003-10-15	Verfahren zur behandlung von narbengewebe
ATE208202T1 (de)	2001-11-15	Verwendung von dimeticon zur behandlung der konstipation
ATE263555T1 (de)	2004-04-15	Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe

Legal Events

Date	Code	Title	Description
2006-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties